Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis, 2021 - 2032
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Supplier landscape
3.2.1 Platform provider
3.2.2 Software provider
3.2.3 Service provider
3.2.4 Distribution channel
3.2.5 End user
3.3 Profit margin analysis
3.4 Technology & innovation landscape
3.5 Patent analysis
3.6 Key news & initiatives
3.7 Regulatory landscape
3.8 Impact forces
3.8.1 Growth drivers
3.8.1.1 Accelerated drug development and discovery
3.8.1.2 Improved patient recruitment
3.8.1.3 Enhanced data analysis and real time monitoring
3.8.1.4 Rising need of personalized medicine
3.8.2 Industry pitfalls & challenges
3.8.2.1 Data privacy and security concerns
3.8.2.2 Integration with existing systems
3.9 Growth potential analysis
3.10 Porter’s analysis
3.10.1 Supplier power
3.10.2 Buyer power
3.10.3 Threat of new entrants
3.10.4 Threat of substitutes
3.10.5 Industry rivalry
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 Market Estimates & Forecast, By Component, 2021 - 2032 ($Bn)
5.1 Key trends
5.2 Software
5.2.1 Phase I
5.2.2 Phase II
5.2.3 Phase III
5.3 Service
5.3.1 Phase I
5.3.2 Phase II
5.3.3 Phase III
Chapter 6 Market Estimates & Forecast, By Technology, 2021 - 2032 ($Bn)
6.1 Key trends
6.2 Machine learning
6.3 Natural Language Processing (NLP)
6.4 Computer vision
6.5 Contextual bots
6.6 Others
Chapter 7 Market Estimates & Forecast, By Application, 2021 - 2032 ($Bn)
7.1 Key trends
7.2 Drug development
7.3 Drug discovery
7.4 Clinical trial management
7.4.1 Patient recruitment
7.4.2 Clinical trial monitoring
7.4.3 Clinical data management
7.4.4 Risk-based monitoring
7.5 Others
Chapter 8 Market Estimates & Forecast, By End User, 2021 - 2032 ($Bn)
8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 Contract Research Organizations (CROs)
8.4 Academic and research institutes
8.5 Others
Chapter 9 Market Estimates & Forecast, By Region, 2021 - 2032 ($Bn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Russia
9.3.7 Nordics
9.3.8 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea
9.4.6 Southeast Asia
9.4.7 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 MEA
9.6.1 UAE
9.6.2 South Africa
9.6.3 Saudi Arabia
9.6.4 Rest of MEA
Chapter 10 Company Profiles
10.1 BenevolentAI Ltd.
10.2 ConcertAI, Inc.
10.3 Exscientia Ltd.
10.4 GNS Healthcare
10.5 Halo Health Systems
10.6 IBM (International Business Machines Corporation)
10.7 Insilico Medicine, Inc.
10.8 IQVIA Holdings Inc.
10.9 Medidata Solutions, Inc.
10.10 Nuance Communications, Inc.
10.11 Numerate
10.12 NVIDIA Corporation
10.13 Owkin Inc.
10.14 Parexel International Corporation
10.15 Prometheus Biosciences Inc.
10.16 Renalytix AI plc
10.17 ReviveMed Ltd.
10.18 Saama Technologies, Inc.
10.19 Sensyne Health plc
10.20 TrialTrove Inc.
